J and J Snack Foods Newswire

Comprehensive Real-Time News Feed for J and J Snack Foods.

Results 1 - 20 of 985 in J and J Snack Foods

  1. Johnson & Johnson Shows Its Strength; I'm Hoping For A 3% YieldRead the original story w/Photo

    8 hrs ago | Seeking Alpha

    J&J isn't getting a lot of praise right now, as high-flying biotech stocks are receiving most of the attention in the health care sector. But on days like April 17, J&J proves once again why it's such a valuable stock.

    Comment?

  2. Massachusetts court upholds $63M judgment against J&JRead the original story

    13 hrs ago | Boston Herald

    The highest court in Massachusetts has upheld a $63 million judgment against the manufacturer of Children's Motrin awarded to a family whose daughter developed a life-threatening disease after taking the over-the-counter medicine. A jury ruled in 2013 that the McNeil Consumer Healthcare unit of Johnson & Johnson failed to provide sufficient warnings about potential side effects.

    Comment?

  3. WWE's Ban of Randy Orton's RKO at Extreme Rules Is a Smart MoveRead the original story w/Photo

    Thursday | BleacherReport

    Raw's April 13 episode featured Randy Orton and Seth Rollins in the last segment. They revealed their stipulations for their upcoming championship match at Extreme Rules.

    Comment?

  4. More Watson Goodness, IBM Announces Health-Focused VerticalRead the original story w/Photo

    Thursday | Forbes.com

    I am a technology evangelist, an investor, a commentator and a business adviser. I am the director of Diversity Limited, a business that is a vehicle for my work in investment, advice and consultancy.

    Comment?

  5. J&J surprise, delight and lead USMNT to 2-0 winRead the original story w/Photo

    Thursday | Examiner.com

    Before a sellout crowd of 64,369 facing bitter rivals Mexico, the USMNT defeated El Tri "dos a cero", the famous 2-0 score line. The USMNT extends its unbeaten run versus Mexico to six games, as El Tri's most recent win against the United States came in the Gold Cup final in 2011.

    Comment?

  6. J & J Snack Foods Schedules Second Quarter Conference CallRead the original story w/Photo

    Wednesday Apr 15 | GlobeNewswire

    J & J Snack Foods Corp. announced today that its conference call to discuss its second quarter 2015 results is scheduled for Tuesday, April 28, 2015 at 10:00 am Eastern time. The Company stated that it expects to release its results for the quarter ended March 28, 2015 at 4:00 pm Eastern time on Monday, April 27, 2015.

    Comment?

  7. Dean & DeLuca, Millennials, and Why Smaller Brands Will Succeed in a Global MarketRead the original story w/Photo

    Wednesday Apr 15 | Forbes.com

    I'm Chairman, North America of Landor Associates, a brand consulting and design firm that specializes in creating agile brands that thrive in today's disruptive, changing market. I work with some of the most powerful brands in the world, and oversee Landor's new business efforts in North America.

    Comment?

  8. Why IBM's Partnership with Medtronic, JNJ and Apple is SignificantRead the original story w/Photo

    Wednesday Apr 15 | Medical Device/Diagnostic Ind.

    IBM is entering healthcare by leveraging its Big Data capabilities and cloud platform, and partnering with Apple, J&J and Medtronic. Why is the partnership notable? The technology giant is formally entering the healthcare market by launching the Watson Health Cloud, a secure and open platform for physicians, researchers, insurers and companies engaged in creating health and wellness solutions.

    Comment?

  9. Pruning Pricey Stocks From Your PortfolioRead the original story w/Photo

    Tuesday Apr 14 | Kiplinger Online

    When the math says sell, it's time to take some profits ... but sometimes you can make an exception or two. I hate to complain about a bull market that just turned six years old and shows no signs of slowing down.

    Comment?

  10. Johnson & Johnson Profit Tops Estimates as Drug Sales RiseRead the original story

    Tuesday Apr 14 | The Washington Post

    First-quarter earnings, excluding one-time items, were $1.56 a share, compared with the $1.53 average estimate of analysts compiled by Bloomberg. Pharmaceutical sales climbed 3 percent to $7.7 billion.

    Comment?

  11. J&J Earnings Beat Estimates; Guidance MixedRead the original story

    Tuesday Apr 14 | Investor's Business Daily

    's sales dropped 4.1% from the year-earlier quarter to $17.4 billion, modestly beating analysts' consensus of $17.3 billion. Earnings declined 4.3% to $1.56 a share, beating estimates by 2 cents.

    Comment?

  12. J&J cuts full-year forecast due to strong dollarRead the original story w/Photo

    Tuesday Apr 14 | HawaiiNews

    Healthcare conglomerate Johnson & Johnson cut its full-year profit forecast on Tuesday, saying it expected a strong dollar to keep hurting its international business. J&J, which reported higher-than-expected quarterly results, warned in January that the dollar's strength could reduce earnings by 42 cents per share this year.

    Comment?

  13. IBM Teams up with Medtronic, Apple, and J Formally Enters Health MarketRead the original story w/Photo

    Tuesday Apr 14 | Medical Device/Diagnostic Ind.

    IBM hopes to leverage its Big Data capabilities into a viable business and teams up with Medtronic, Johnson & Johnson, and Apple to transform personal healthcare. IBM announced Tuesday that it has formally created a business unit called IBM Watson Health, based in Boston, that will execute on its overarching goal to transform personal healthcare.

    Comment?

  14. Wall Street edges up after JPMorgan, J&J resultsRead the original story

    Tuesday Apr 14 | Buenos Aires Herald

    US stocks were flat today as investors digested the initial major earnings of the first-quarter reporting season, which showed some weakness though companies topped lowered expectations. The Dow Jones industrial average rose 28.63 points, or 0.16 percent, to 18,005.67, the S&P 500 gained 0.01 points, or 0 percent, to 2,092.44 and the Nasdaq Composite dropped 17.81 points, or 0.36 percent, to 4,970.44.

    Comment?

  15. IBM partners with Apple, Canadian firm Medtronic, J&JRead the original story

    Tuesday Apr 14 | ITWorld Canada

    IBM Corp., collaborating closely with Canadian medical technology and services firm Medtronic Canada Ltd., Apple Inc., and Johnson & Johnson to form a new health unit. Big Blue is using its super computer-based Watson Health Cloud platform to develop new health-based offerings that will use information collected from millions of personal health, medical and fitness devices built by Apple and Medtronics.

    Comment?

  16. Global Markets-Oil up on U.S. production bets, stocks flatRead the original story

    Tuesday Apr 14 | Reuters

    Crude prices rose on Tuesday after a surprise drop in expectations for U.S. shale oil production while the dollar fell and stocks edged lower with investors focused on U.S. corporate earnings and retail sales data. U.S. stocks were little changed as gains in banks JPMorgan and Wells Fargo were offset by a full-year earnings forecast downgrade from Johnson & Johnson due to the impact of dollar strength.

    Comment?

  17. Caution: Slowing Growth Ahead for J&JRead the original story

    Tuesday Apr 14 | Morningstar

    Strong drug sales helped wide-moat J&J report a steady quarter, but increasing competitive threats to leading drugs and a relatively weak late-stage pipeline will be headwinds in the future. Johnson & Johnson reported first-quarter results below our expectations but slightly ahead of consensus projections, as strong drug sales helped mitigate weak device sales.

    Comment?

  18. Wall St. edges up after JPMorgan, J&J resultsRead the original story w/Photo

    Tuesday Apr 14 | Channelnewsasia.com

    U.S. stocks rose modestly on Tuesday as investors digested the initial major earnings of the first-quarter reporting season, which showed some weakness despite companies topping lowered expectations. NEW YORK: U.S. stocks rose modestly on Tuesday as investors digested the initial major earnings of the first-quarter reporting season, which showed some weakness despite companies topping lowered expectations.

    Comment?

  19. Us Stocks-Futures point to flat open after JPMorgan, J&J resultsRead the original story

    Tuesday Apr 14 | Reuters

    U.S. stock index futures pointed to a flat open on Tuesday as investors digested the first major earnings of the first-quarter reporting season, which showed some weakness despite companies topping lowered expectations. JPMorgan Chase & Co posted stronger-than-expected earnings growth, helped by a rebound in fixed-income trading.

    Comment?

  20. Q1 Revenues Drop at J&JRead the original story w/Photo

    Tuesday Apr 14 | HAPPI/Household & PP Industry

    Johnson & Johnson's Q1 sales were $17.4 billion, a decrease of 4.1% compared to the first quarter of 2014. Operational results increased 3.1% and the negative impact of currency was 7.2%.

    Comment?